Abstract
Many agents are available to treat acute coronary syndromes (ACS), yet limited information is available about their use from a multinational perspective. The objective of this report was to describe patterns of use of antithrombotic and antiplatelet therapies in patients with the spectrum of ACS through the use of data from the Global Registry of Acute Coronary Events (GRACE).
Original language | English |
---|---|
Pages (from-to) | 999-1006 |
Number of pages | 8 |
Journal | American Heart Journal |
Volume | 146 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2003 |
Keywords
- Acute Disease
- Aged
- Angioplasty, Balloon, Coronary
- Biological Markers
- Coronary Thrombosis
- Female
- Fibrinolytic Agents
- Heparin
- Heparin, Low-Molecular-Weight
- Hospitalization
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Platelet Aggregation Inhibitors
- Registries
- Regression Analysis
- Statistics, Nonparametric
- Syndrome
- Troponin